PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated IgG for enhanced ADCC

Por um escritor misterioso

Last updated 08 abril 2025

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

Frontiers Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies

Cancers, Free Full-Text

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

JCI - Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models

Loop Grafting between Similar Local Environments for Fc-Silent Antibodies

PDF) Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity

PDF) Cross-reactivity of mouse IgG subclasses to human Fc gamma receptors: Antibody deglycosylation only eliminates IgG2b binding

PDF) Beyond antibody fucosylation: α-(1,6)-fucosyltransferase (Fut8) as a potential new therapeutic target for cancer immunotherapy

Frontiers Fc-Linked IgG N-Glycosylation in FcγR Knock-Out Mice

Isotype selection for antibody‐based cancer therapy - Vukovic - 2021 - Clinical & Experimental Immunology - Wiley Online Library

Fc-engineered antibodies with immune effector functions completely abolished

FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities: Trends in Immunology

Recomendado para você